Soft Tissue Repair Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Breast Reconstruction Market, Hernia Repair Market, and 3 more
2023년 미국 연조직 복구 시장 규모는 30억 달러 이상이었습니다. 이 시장 예측기간인 CAGR은 7.2%로 예상되며 약 50억 달러에 달할 것으로 예측되고 있습니다.
미국의 인구 역학 변화는 연조직 수리 시장에 긍정적인 영향을 미칩니다. 노화와 비만률 증가는 탈장이나 신경 손상과 같은 질병의 유병률을 높입니다. 당뇨병 환자 수는 2010년부터 2025년 사이에 64% 급증할 것으로 예상됩니다. 게다가 65세 이상의 미국인 비율은 2016년의 15.2%에서 2034년에는 23.4%로 상승해, 노인 인구는 8,000만명 가까이에 달할 전망입니다.
미국의 연조직 수리 시장에는 3개의 주요 진출기업: Becton Dickinson(BD), AbbVie, Integra LifeSciences가 존재합니다. Becton Dickinson(BD)은 광범위한 탈장 수리 제품 포트폴리오, 특히 Phasix(R) 재흡수가능한 합성 제품 라인에서 우위를 차지하고 있습니다.
AbbVie는 유방 재건과 탈장 수리가 뛰어나며 외과의사들 사이에서 AlloDerm(R)이 최고 선택이 되고 있습니다. Integra LifeSciences는 신경·경막 수복으로 돌출하고 2023년 시장을 선도했습니다.
이 보고서는 미국 연조직 수리 시장에 대해 조사했으며, 시장 개요와 함께 부문별 동향, COVID-19의 영향 분석, 시장 성장 촉진요인 및 저해 요인, 경쟁 시장 점유율 분석 및 시장 진출 기업 프로파일 등의 정보를 제공합니다.
목차
주요 요약
조사 방법
미국 연조직 복구 시장에 대한 COVID-19의 영향
질병 개요
- 기본적인 해부학
- 질병의 치료와 진단
- 환자 인구통계
제품 평가
- 소개
- 제품 포트폴리오
- 규제상의 문제와 리콜
- 임상시험
미국 연조직 수리 시장 개요
- 소개
- 시장 개요와 트렌드 분석
- 성장 촉진요인과 억제요인
- 경쟁 시장 점유율 분석
- 합병과 인수
- 기업 프로파일
- AbbVie
- Artivion
- Axogen
- Becton Dickinson
- Integra LifeSciences
- Medtronic
- MTF Biologics
- Stryker
- WL Gore
- SWOT 분석
수기 건수
유방 재건 시장
탈장 수리 시장
경막 복구 시장
신경 복구 시장
심장혈관 패치 복구 시장
JHS
In 2023, the U.S. soft tissue repair market was valued at over $3 billion, and it is projected to grow at a CAGR of 7.2% over the forecast period, reaching approximately $5 billion. This comprehensive report on the U.S. soft tissue repair market covers breast reconstruction, hernia repair, dural repair, nerve repair, and cardiovascular patch repair.MARKET REPORT
COVERAGE:
Unit Sales, Average Selling Prices, Market Value & Growth Trends
Procedure Volumes
10-Year Scope (2020-2030)
Key Market Drivers & Limiters by Segment
Competitive Landscape and Market Shares by Segment
Recent Mergers & Acquisitions
Disease Overviews and Demographic Insights
Company Profiles, Product Offerings, and SWOT Analyses for Major Players
U.S. SOFT TISSUE REPAIR MARKET TRENDS:
Shifting U.S. demographics are positively influencing the soft tissue repair market. Aging and increasing obesity rates raise the prevalence of conditions like hernias and nerve damage. The number of individuals with diabetes is expected to surge by 64% between 2010 and 2025. Additionally, the percentage of Americans aged 65 and over will rise from 15.2% in 2016 to 23.4% by 2034, bringing the elderly population to nearly 80 million.U.S.
SOFT TISSUE REPAIR MARKET COMPETITION:
There are three key players in the U.S. soft tissue repair market: Becton Dickinson (BD), AbbVie, and Integra LifeSciences.Becton Dickinson (BD) dominates with its expansive hernia repair portfolio, particularly the Phasix(R) resorbable synthetic product line.
AbbVie holds a strong second position, excelling in breast reconstruction and hernia repair, with AlloDerm(R) as a top choice among surgeons.
Integra LifeSciences stands out in nerve and dural repair, where it led the market in 2023.
MARKET SEGMENTATION OVERVIEW:
Breast Reconstruction Market - Comprising allografts, xenografts, and synthetic materials.
Hernia Repair Market - Encompassing allograft, xenograft, and synthetic devices used for inguinal, ventral, and hiatal hernia repairs.
Dural Repair Market - Divided into allograft, xenograft, and synthetic material categories.
Nerve Repair Market - Includes wraps, tubes, grafts, and cap products for nerve repair.
Cardiovascular Repair Market - Consists of both cardiac and vascular patches.
RESEARCH SCOPE SUMMARY:
Geographic Focus: United States
Base Year: 2023
Forecast Period: 2024-2030
Historical Data: 2020-2022
Quantitative Data: Market Size, Shares, Forecasts, Growth Rates, Units Sold, and Average Selling Prices
Qualitative Data: Market Trends, Limiters, Competitive Analysis, SWOT, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews
Data Sources: Primary industry interviews, physician and regulatory data, hospital and import/export data
TABLE OF CONTENT
TABLE of CONTENTS
List of Figures
List of Charts
executive summary
U.S. Soft Tissue Repair Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedures Included
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
research methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE U.S. Soft Tissue repair Market
- 2.1 Introduction
- 2.2 Analysis By Market Segment
- 2.2.1 Worst Case Scenario
- 2.2.2 Base Case Scenario
- 2.2.3 Best Case Scenario
Disease Overview
- 3.1 Basic Anatomy
- 3.2 Disease Treatment and Diagnostic
- 3.2.1 Breast Cancer
- 3.2.2 Cardiovascular Tissue Repair
- 3.2.3 Dural Tears and Cerebrospinal Fluid Leakage Prevention
- 3.2.4 Hernia
- 3.2.5 Peripheral Vasculature Repair
- 3.2.6 Traumas and Burns
- 3.3 Patient Demographics
- 3.3.1 Breast Cancer Statistics
- 3.3.2 Cardiovascular Disease Statistics
- 3.3.3 Hernia Repair Statistics
- 3.3.4 Periodontitis Statistics
- 3.3.5 Peripheral Vascular Disease (PVD) Statistics
- 3.3.6 Traumatic and Sport-Related Injuries Statistics
Product Assessment
- 4.1 Introduction
- 4.2 Product Portfolios
- 4.2.1 Breast Reconstruction Market
- 4.2.2 Hernia Repair Market
- 4.2.3 Dural Repair Market
- 4.2.4 Nerve Repair Market
- 4.2.5 Cardiovascular Repair
- 4.3 Regulatory Issues and Recalls
- 4.3.1 Hernia Repair
- 4.3.2 Dural Repair
- 4.3.3 Nerve Repair Market FDA Recalls
- 4.3.4 Cardiovascular Repair
- 4.4 Clinical Trials
- 4.4.1 Breast Reconstruction
- 4.4.2 Hernia Repair
- 4.4.3 Dural Repair
- 4.4.4 Nerve Repair
- 4.4.5 Cardiovascular Repair
U.S. soft tissue repair Market Overview
- 5.1 Introduction
- 5.2 Market Overview & Trend Analysis
- 5.3 Drivers and Limiters
- 5.3.1 Market Drivers
- 5.3.2 Market Limiters
- 5.4 Competitive Market Share Analysis
- 5.5 Mergers and Acquisitions
- 5.6 Company Profiles
- 5.6.1 AbbVie
- 5.6.2 Artivion
- 5.6.3 Axogen
- 5.6.4 Becton Dickinson
- 5.6.5 Integra LifeSciences
- 5.6.6 Medtronic
- 5.6.7 MTF Biologics
- 5.6.8 Stryker
- 5.6.9 W.L. Gore
- 5.7 SWOT Analysis
- 5.7.1 AbbVie
- 5.7.2 Artivion
- 5.7.3 Axogen
- 5.7.4 Becton Dickinson
- 5.7.5 Integra LifeSciences
- 5.7.6 Medtronic
- 5.7.7 MTF Biologics
- 5.7.8 Stryker
- 5.7.9 W.L. Gore
Procedure Numbers
- 6.1 Introduction
- 6.2 Procedures
- 6.2.1 Breast Reconstruction Procedures
- 6.2.1.1 Breast Reconstruction Procedures by Method
- 6.2.1.1.1 Implant-Based Breast Reconstruction Procedures
- 6.2.1.1.2 Autologous Breast Reconstruction Procedures
- 6.2.1.2 Breast Reconstruction Procedures by Care Setting
- 6.2.2 Hernia Repair Procedures
- 6.2.2.1 Hernia Repair Procedures by Type
- 6.2.2.2 Hernia Repair Procedures by Care Setting
- 6.2.2.3 Hernia Repair Procedures by Robotic Assistance
- 6.2.3 Dural Repair Procedures
- 6.2.4 Cardiovascular Patch Repair Procedures
- 6.2.5 Nerve Repair Procedures
Breast Reconstruction Market
- 7.1 Introduction
- 7.2 Market Overview
- 7.2.1 Breast Reconstruction Market by Material Type
- 7.2.2 Breast Reconstruction Market by Procedure Type
- 7.2.3 Breast Reconstruction Market by Care Setting
- 7.3 Market Analysis and Forecast
- 7.3.1 Breast Reconstruction Market
- 7.3.2 Allograft Breast Reconstruction Market
- 7.3.3 Xenograft Breast Reconstruction Market
- 7.3.4 Synthetic Breast Reconstruction Market
- 7.3.5 Breast Reconstruction Market by Procedure Type
- 7.3.5.1 Implant-Based Breast Reconstruction Market
- 7.3.5.2 Autologous Breast Reconstruction Market
- 7.3.6 Breast Reconstruction Market by Care Setting
- 7.3.6.1 Hospital Breast Reconstruction Market
- 7.3.6.2 Non-Hospital Breast Reconstruction Market
- 7.4 Drivers and Limiters
- 7.4.1 Market Drivers
- 7.4.2 Market Limiters
- 7.5 Competitive Market Share Analysis
Hernia Repair Market
- 8.1 Introduction
- 8.2 Market Overview
- 8.2.1 Hernia Repair Market by Segment
- 8.2.2 Hernia Repair Market by Material Type
- 8.3 Market Analysis and Forecast
- 8.3.1 Hernia Repair Market
- 8.3.2 Ventral Hernia Repair Market
- 8.3.2.1 Allograft Ventral Hernia Repair Market
- 8.3.2.2 Xenograft Ventral Hernia Repair Market
- 8.3.2.2.1 Reinforced Xenograft Ventral Hernia Repair Market
- 8.3.2.2.2 Non-Reinforced Xenograft Ventral Hernia Repair Market
- 8.3.2.3 Synthetic Ventral Hernia Repair Market
- 8.3.2.3.1 Resorbable Synthetic Ventral Hernia Repair Market
- 8.3.2.3.2 Non-Resorbable Synthetic Ventral Hernia Repair Market
- 8.3.2.4 Ventral Hernia Repair Market by Care Setting
- 8.3.2.4.1 Hospital Ventral Hernia Repair Market
- 8.3.2.4.2 Non-Hospital Ventral Hernia Repair Market
- 8.3.3 Inguinal Hernia Repair Market
- 8.3.3.1 Allograft Inguinal Hernia Repair Market
- 8.3.3.2 Xenograft Inguinal Hernia Repair Market
- 8.3.3.3 Synthetic Inguinal Hernia Repair Market
- 8.3.3.4 Inguinal Hernia Repair Market by Care Setting
- 8.3.3.4.1 Hospital Inguinal Hernia Repair Market
- 8.3.3.4.2 Non-Hospital Inguinal Hernia Repair Market
- 8.3.4 Hiatal Hernia Repair Market
- 8.3.4.1 Allograft Hiatal Hernia Repair Market
- 8.3.4.2 Xenograft Hiatal Hernia Repair Market
- 8.3.4.2.1 Reinforced Xenograft Hiatal Hernia Repair Market
- 8.3.4.2.2 Non-Reinforced Xenograft Hiatal Hernia Repair Market
- 8.3.4.3 Synthetic Hiatal Hernia Repair Market
- 8.3.4.3.1 Resorbable Synthetic Hiatal Hernia Repair Market
- 8.3.4.3.2 Non-Resorbable Synthetic Hiatal Hernia Repair Market
- 8.3.4.4 Hiatal Hernia Repair Market by Care Setting
- 8.3.4.4.1 Hospital Hiatal Hernia Repair Market
- 8.3.4.4.2 Non-Hospital Hiatal Hernia Repair Market
- 8.4 Drivers and Limiters
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
- 8.5 Competitive Market Share Analysis
Dural repair Market
- 9.1 Introduction
- 9.2 Market Overview
- 9.2.1 Dural Repair Market by Material Type
- 9.2.2 Dural Repair Market by Care Setting
- 9.3 Market Analysis and Forecast
- 9.3.1 Dural Repair Market
- 9.3.2 Dural Repair Market by Material Type
- 9.3.2.1 Allograft Dural Repair Market
- 9.3.2.2 Xenograft Dural Repair Market
- 9.3.2.3 Synthetic Dural Repair Market
- 9.3.3 Dural Repair Market by Care Setting
- 9.3.3.1 Hospital Dural Repair Market
- 9.3.3.2 Non-Hospital Dural Repair Market
- 9.4 Drivers and Limiters
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
- 9.5 Competitive Market Share Analysis
Nerve repair Market
- 10.1 Introduction
- 10.2 Market Overview
- 10.2.1 Nerve Repair Market by Product Type
- 10.2.2 Nerve Repair Market by Care Setting
- 10.3 Market Analysis and Forecast
- 10.3.1 Nerve Repair Market
- 10.3.2 Nerve Repair Market by Product Type
- 10.3.2.1 Nerve Wrap Market
- 10.3.2.2 Nerve Graft Market
- 10.3.2.3 Nerve Tube Market
- 10.3.2.4 Nerve Cap Market
- 10.3.3 Nerve Repair Market by Care Setting
- 10.3.3.1 Hospital Nerve Repair Market
- 10.3.3.2 Non-Hospital Nerve Repair Market
- 10.4 Drivers and Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
- 10.5 Competitive Market Share Analysis
Cardiovascular Patch repair Market
- 11.1 Introduction
- 11.2 Market Overview
- 11.2.1 Cardiovascular Patch Repair Market by Material Type
- 11.2.2 Cardiovascular Patch Repair Market by Segment
- 11.3 Market Analysis and Forecast
- 11.3.1 Cardiovascular Patch Repair Market
- 11.3.2 Cardiac Patch Market
- 11.3.2.1 Allograft Cardiac Patch Market
- 11.3.2.2 Xenograft Cardiac Patch Market
- 11.3.2.3 Synthetic Cardiac Patch Market
- 11.3.3 Vascular Patch Market
- 11.3.3.1 Xenograft Vascular Patch Market
- 11.3.3.2 Synthetic Vascular Patch Market
- 11.4 Drivers and Limiters
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
- 11.5 Competitive Market Share Analysis
Abbreviations
